113 related articles for article (PubMed ID: 11326538)
1. Connexin-43 expression in oral-derived human osteoblasts after transforming growth factor-beta and prostaglandin E2 exposure.
Adamo CT; Mailhot JM; Smith AK; Borke JL
J Oral Implantol; 2001; 27(1):25-31. PubMed ID: 11326538
[TBL] [Abstract][Full Text] [Related]
2. Effects of transforming growth factor beta on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts.
Harris SE; Bonewald LF; Harris MA; Sabatini M; Dallas S; Feng JQ; Ghosh-Choudhury N; Wozney J; Mundy GR
J Bone Miner Res; 1994 Jun; 9(6):855-63. PubMed ID: 8079661
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2 enhances transforming growth factor-beta 1 and TGF-beta receptors synthesis: an in vivo and in vitro study.
Ramirez-Yañez GO; Hamlet S; Jonarta A; Seymour GJ; Symons AL
Prostaglandins Leukot Essent Fatty Acids; 2006 Mar; 74(3):183-92. PubMed ID: 16504491
[TBL] [Abstract][Full Text] [Related]
4. Effects of transforming growth factor-beta and IL-1 alpha on prostaglandin synthesis in serum-deprived osteoblastic cells.
Marusić A; Kalinowski JF; Harrison JR; Centrella M; Raisz LG; Lorenzo JA
J Immunol; 1991 Apr; 146(8):2633-8. PubMed ID: 1707913
[TBL] [Abstract][Full Text] [Related]
5. A recombinant human TGF-beta1 fusion protein with collagen-binding domain promotes migration, growth, and differentiation of bone marrow mesenchymal cells.
Andrades JA; Han B; Becerra J; Sorgente N; Hall FL; Nimni ME
Exp Cell Res; 1999 Aug; 250(2):485-98. PubMed ID: 10413602
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin mediated modulation of transforming growth factor-beta metabolism in primary mouse osteoblastic cells in vitro.
Klein-Nulend J; Semeins CM; Burger EH
J Cell Physiol; 1996 Jul; 168(1):1-7. PubMed ID: 8647903
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta suppresses tumor necrosis factor alpha-induced matrix metalloproteinase-9 expression in monocytes.
Vaday GG; Schor H; Rahat MA; Lahat N; Lider O
J Leukoc Biol; 2001 Apr; 69(4):613-21. PubMed ID: 11310848
[TBL] [Abstract][Full Text] [Related]
8. Pulsed electromagnetic fields affect phenotype and connexin 43 protein expression in MLO-Y4 osteocyte-like cells and ROS 17/2.8 osteoblast-like cells.
Lohmann CH; Schwartz Z; Liu Y; Li Z; Simon BJ; Sylvia VL; Dean DD; Bonewald LF; Donahue HJ; Boyan BD
J Orthop Res; 2003 Mar; 21(2):326-34. PubMed ID: 12568966
[TBL] [Abstract][Full Text] [Related]
9. Arachidonic acid and prostaglandin E2 influence human osteoblast (MG63) response to titanium surface roughness.
Dean DD; Campbell CM; Gruwell SF; Tindall JW; Chuang HH; Zhong W; Schmitz JP; Sylvia VL
J Oral Implantol; 2008; 34(6):303-12. PubMed ID: 19133484
[TBL] [Abstract][Full Text] [Related]
10. Growth factor stimulation of bone healing. Effects on osteoblasts, osteomies, and implants fixation.
Lind M
Acta Orthop Scand Suppl; 1998 Oct; 283():2-37. PubMed ID: 9856074
[TBL] [Abstract][Full Text] [Related]
11. PGE2 induces the gene expression of bone matrix metalloproteinase-1 in mouse osteoblasts by cAMP-PKA signaling pathway.
Kim CH; Park YG; Noh SH; Kim YK
Int J Biochem Cell Biol; 2005 Feb; 37(2):375-85. PubMed ID: 15474982
[TBL] [Abstract][Full Text] [Related]
12. Osteoblast proliferation and differentiation on dentin slices are modulated by pretreatment of the surface with tetracycline or osteoclasts.
Schwartz Z; Lohmann CH; Wieland M; Cochran DL; Dean DD; Textor M; Bonewald LF; Boyan BD
J Periodontol; 2000 Apr; 71(4):586-97. PubMed ID: 10807123
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin-dependent activation of ERK mediates cell proliferation induced by transforming growth factor beta in mouse osteoblastic cells.
Ghayor C; Rey A; Caverzasio J
Bone; 2005 Jan; 36(1):93-100. PubMed ID: 15664007
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of cytokines in osteoblasts cultured on enamel matrix derivative.
Lee AZ; Jiang J; He J; Safavi KE; Spangberg LS; Zhu Q
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jul; 106(1):133-8. PubMed ID: 18585627
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta 1 (TGF-beta1) prevents the age-dependent decrease in bone formation in human osteoblast/implant cultures.
Zhang H; Aronow MS; Gronowicz GA
J Biomed Mater Res A; 2005 Oct; 75(1):98-105. PubMed ID: 16044414
[TBL] [Abstract][Full Text] [Related]
16. Growth on type I collagen promotes expression of the osteoblastic phenotype in human osteosarcoma MG-63 cells.
Andrianarivo AG; Robinson JA; Mann KG; Tracy RP
J Cell Physiol; 1992 Nov; 153(2):256-65. PubMed ID: 1429847
[TBL] [Abstract][Full Text] [Related]
17. Endogenous prostaglandin E2 and insulin-like growth factor 1 can modulate the levels of parathyroid hormone receptor in human osteoarthritic osteoblasts.
Hilal G; Massicotte F; Martel-Pelletier J; Fernandes JC; Pelletier JP; Lajeunesse D
J Bone Miner Res; 2001 Apr; 16(4):713-21. PubMed ID: 11315999
[TBL] [Abstract][Full Text] [Related]
18. The shunt from the cyclooxygenase to lipoxygenase pathway in human osteoarthritic subchondral osteoblasts is linked with a variable expression of the 5-lipoxygenase-activating protein.
Maxis K; Delalandre A; Martel-Pelletier J; Pelletier JP; Duval N; Lajeunesse D
Arthritis Res Ther; 2006; 8(6):R181. PubMed ID: 17156456
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of transforming growth factor-beta 1 and bone morphogenetic protein 4 on gene expression and differentiated function of preosteoblasts.
Zhou H; Hammonds RG; Findlay DM; Martin TJ; Ng KW
J Cell Physiol; 1993 Apr; 155(1):112-9. PubMed ID: 8385674
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of prostaglandin E2 production by interleukin-1 alpha and transforming growth factor alpha in osteoblastic MC3T3-E1 cells.
Harrison JR; Lorenzo JA; Kawaguchi H; Raisz LG; Pilbeam C
J Bone Miner Res; 1994 Jun; 9(6):817-23. PubMed ID: 8079657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
